Skip to main content

Digital Health Advisory Committee

News


Abstract

The Digital Health Advisory Committee (DHAC) advises the Commissioner of Food and Drugs on issues related to digital health technologies (DHTs), providing relevant expertise and perspective to improve the FDA's understanding of the benefits, risks, and clinical outcomes associated with the use of DHTs.
Key Data

  • Publication Date
    12 September 2025
  • Primary Author
    U.S. Food and Drug Administration
  • Source
    U.S. Food and Drug Administration
  • Language
    English
Click below to visit original source: